Taurochenodeoxycholic acid sodium
Cat.No:IT5180 Solarbio
CAS:6009-98-9
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to light yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Apoptosis >
Taurochenodeoxycholic acid sodiumCAS:6009-98-9
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to light yellow Solid
Qty:
Size:
CAS | 6009-98-9 |
Name | Taurochenodeoxycholic acid sodium |
Molecular Formula | C26H44NNaO6S |
Molecular Weight | 521.69 |
Solubility | Soluble in DMSO ≥10mg/mL(Need ultrasonic) |
Purity | ≥98% |
Appearance | Off-white to light yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 684-591-6 |
MDL | MFCD00036745 |
SMILES | CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C.[Na+] |
InChIKey | IYPNVUSIMGAJFC-HLEJRKHJSA-M |
InChI | InChI=1S/C26H45NO6S.Na/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29;/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);/q;+1/p-1/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-;/m1./s1 |
PubChem CID | 23664008 |
Target Point | Apoptosis |
Passage | Apoptosis |
Background | It is one of the main bioactive substances of animal bile acids, can induce apoptosis, and has obvious anti-inflammatory and immunomodulatory effects. |
Unit | Bottle |
Specification | 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.